GlassScriptPhysician profile
Wells Stewart
NPI 1265881502
$23,917.14
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,734 · 2020: $585 · 2021: $354 · 2022: $3,241 · 2023: $2,673 · 2024: $1,500 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $4,749 · Travel and Lodging: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,400.00 |
| Food and Beverage | $4,749.49 |
| Travel and Lodging | $853.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21,413.68 | 2019-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $1,119.95 | 2019-2025 | Persona, Comprehensive Shoulder System, Comprehensive |
| Depuy Synthes Sales INC. | $591.03 | 2021-2024 | Velys, Emphasys |
| Medical Device Business Services, INC. | $430.88 | 2020-2022 | |
| Si-Bone, INC. | $290.49 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $30.68 | 2025 | Exparel |
| Melinta Therapeutics, LLC | $26.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wells Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.